Nywening, T. M. (2018). Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma. BMJ Publishing Group.
Chicago Style (17th ed.) CitationNywening, T. M. Targeting Both Tumour-associated CXCR2+ Neutrophils and CCR2+ Macrophages Disrupts Myeloid Recruitment and Improves Chemotherapeutic Responses in Pancreatic Ductal Adenocarcinoma. BMJ Publishing Group, 2018.
MLA (9th ed.) CitationNywening, T. M. Targeting Both Tumour-associated CXCR2+ Neutrophils and CCR2+ Macrophages Disrupts Myeloid Recruitment and Improves Chemotherapeutic Responses in Pancreatic Ductal Adenocarcinoma. BMJ Publishing Group, 2018.
Warning: These citations may not always be 100% accurate.